Maartje van den Biggelaar Selected Research

Maartje van den Biggelaar Research Topics

5	Hemophilia A (Haemophilia) 12/2020 - 05/2009
4	Hemorrhage 04/2024 - 01/2019
4	Infections 03/2024 - 01/2018
4	Neoplasms (Cancer) 01/2024 - 01/2017
2	Thrombosis (Thrombus) 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 10/2019
1	von Willebrand Diseases (von Willebrand's Disease) 04/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023
1	COVID-19 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Thrombotic Thrombocytopenic Purpura 01/2021
1	Hermansky Pudlak syndrome 2 10/2019
1	Disease Susceptibility (Diathesis) 10/2019
1	Neutropenia 10/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2019
1	Microvillus inclusion disease 01/2018
1	Hemolytic-Uremic Syndrome 01/2014
1	Diarrhea 01/2014

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2009
3	von Willebrand FactorIBA 04/2024 - 01/2011
3	CytokinesIBA 03/2024 - 01/2018
3	Factor VIII (Coagulation Factor VIII)IBA 05/2012 - 01/2011
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	Hemostatics (Antihemorrhagics)IBA 06/2022 - 01/2019
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 10/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2024
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	AnticoagulantsIBA 01/2022
1	Erythropoietin FDA Link 01/2022
1	AutoantibodiesIBA 01/2021
1	EnzymesIBA 12/2020
1	Adaptor Protein Complex 3IBA 10/2019
1	InterleukinsIBA 10/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Shiga Toxin (Shigella Toxin)IBA 01/2014
1	Peptides (Polypeptides)IBA 02/2012

1	Therapeutics 05/2009